Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may help some male chronic pelvic pain patients, but more research needed.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Using buccal mucosa for hypospadias repair in children is effective and reduces complications.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Robotics in facial injections offers precision but is costly and lacks personal touch.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Both terazosin and baclofen effectively reduce pain in young men with chronic testicular pain, with no difference in their effectiveness.

PRP injections effectively improve stress urinary incontinence in women.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

The document suggests that for better patient satisfaction in hair transplants, high-quality photos are needed, and using a narrow donor strip might lead to fewer grafts and dissatisfaction, but filling the scar with FUE grafts and using tranexamic acid can improve results.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Sabal and Urtica extract works as well as finasteride for treating BPH, with fewer side effects.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

The document aimed to understand how certain treatments affect blood vessel growth in rat prostates.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Finasteride effectively reduces prostate size and symptoms in most BPH patients.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.